Pharmafile Logo
Pharmafocus logo
Advanced Search

AstraZeneca

Showing 15 posts of 785 posts found.

az_palmer

Three appointments in AstraZeneca’s global media relations team

January 11, 2016
Medical Communications AstraZeneca

Neil Burrows has joined as head of global media relations, following Esra Erkal-Paler’s promotion to head of global external communications.Burrows …

Appointment
Dr Reddy's generic nexium

Dr Reddy’s relaunches generic Nexium in blue after AstraZeneca lawsuit

January 6, 2016
Manufacturing and Production, Sales and Marketing AstraZeneca, Dr Reddy's, Nexium, acid reflux, esomeprazole, lawsuit, purple pill

Dr Reddy’s has relaunched its generic version of AstraZeneca’s blockbuster heartburn drug Nexium  in the US, changing the colour from …

News
2000px-food_and_drug_administration_logo

FDA approves AstraZeneca’s gout drug Zurampic

December 23, 2015
Sales and Marketing AstraZeneca, FDA, Zurampic, gout, lensinurad

The US FDA has approved AstraZeneca’s Zurampic to treat high levels of uric acid in the blood. The drug is …

News
EU flag

Three AstraZeneca drugs recommended by EMA committee

December 21, 2015
Sales and Marketing AstraZeneca, Brilique, CHMP, EMA, Portrazza, Tagrisoo, lesinurad, lilly

The EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended several new drugs in its latest meeting, including …

News

AstraZeneca to buy majority share in Acerta Pharma

December 17, 2015
Sales and Marketing Acerta Pharma, AstraZeneca, acalabrutinib, acquisitions, mergers

Following several days of speculation, AstraZeneca has announced that it has agreed a deal to buy Acerta Pharma, a developer …

News

AstraZeneca to acquire Takeda’s respiratory franchise

December 16, 2015
Manufacturing and Production, Research and Development AstraZeneca, China, Takeda, investment, respiratory

AstraZeneca and Takeda have agreed a multi-million pound deal for AZ to acquire the Japanese firm’s core respiratory business, including …

News
AZ Macclesfield site

AstraZeneca invests £75m to future-proof production facilities

December 15, 2015
Manufacturing and Production AstraZeneca, manufacturing, production

AstraZeneca says it will invest £75m to future-proof a key production facility in Macclesfield, Cheshire. The upgrade to the 48-year-old …

News
AZ building

AstraZeneca in $5bn Acerta buyout talks

December 14, 2015
Sales and Marketing Acerta Pharma, AstraZeneca, acalabrutinib, acquisitions, blood cancer, buyout, chronic lymphocytic leukaemia, mergers, takeover

AstraZeneca has confirmed it is in negotiations to buy cancer drug developer Acerta Pharma BV for more than $5 billion …

News
Lynparza

NICE recommends AstraZeneca’s Lynparza after price reduction

December 11, 2015
Medical Communications, Sales and Marketing AstraZeneca, NICE, fallopian tube cancer, lynparza, olaparib, ovarian cancer, peritoneal cancer

NICE has recommended AstraZeneca’s Lynparza for maintenance treatment of relapsed ovarian, fallopian tube and peritoneal cancer. In draft guidance the …

News
AZ_scientist

AstraZeneca deal to delve into the secretome

December 11, 2015
Medical Communications, Research and Development AstraZeneca, MedImmune, biologics, secretome

MedImmune, the biologics research and development arm of pharma giant AstraZeneca, has signed a collaboration with Swedish universities and research …

News
MHRA

Early UK access for AstraZeneca lung cancer drug

December 9, 2015
AstraZeneca, Early Access to Medicines Scheme, Tagrissa, eams, lung cancer, non small cell lung cancer, non-small cell lung cancer, osimertinib

UK patients will be among the first in Europe to have free access to AstraZeneca’s cancer drug osimertinib, after the …

News
Turing logo

Top five pharma controversies of 2015 (so far)

November 20, 2015
Medical Communications, Sales and Marketing AstraZeneca, Martin Shkreli, Philidore, Takeda, Turing Pharmaceutical, Valeant, Warner Chilcott, controversies, fraud, reputation, tax avoidance, turing

5. AstraZeneca forced to deny tax avoidance allegations

Feature
az_pacal_soriot

AstraZeneca earns ‘speedy’ FDA approval for lung cancer drug

November 13, 2015
AZD9291, AstraZeneca, Tagrisso, lung cancer

The FDA has approved AstraZeneca’s new lung cancer drug Tagrisso, in a record two and half years from development, under …

News
astrazeneca image

AstraZeneca acquires ZS Pharma for $2.7bn, announces Q3 results

November 6, 2015
Medical Communications AstraZeneca, M&A, MA, ZS Pharma, ZS-9, acquisitions, financial results, hyperkalaemia, mergers

AstraZeneca has announced its acquisition of ZS Pharma for an all-cash total of $2.7 billion. In the latest mega-money deal …

News
AZ sign

FDA backs AZ gout drug despite safety concerns

October 26, 2015
Sales and Marketing AstraZeneca, Zurampic, gout, lesinurad

FDA reviewers have recommended approving AstraZeneca’s new gout therapy Zurampic, which the company purchased in a $1.3 billion buyout, despite …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025